Rat fetuses were paralyzed by daily transuterine injections of curare from day 18 of gestation until term (day 21). The following anomalies were noted at the time of delivery: multiple joint contractures, pulmonary hypoplasia, micrognathia, fetal growth retardation, short umbilical cords, and polyhydramnios. Neither sham-operated nor untouched littermate control fetuses had any of these anomalies. The group of anomalies (or deformation sequence) obtained with this animal model is presumed to result from the paralytic effect of curare. This phenotype bears a striking resemblance to the syndrome of ankyloses, facial anomalies, and pulmonary hypoplasia (also known as Pena and Shokeir I), presumably inherited in an autosomal recessive manner. I...
The Adriamycin rat model (ARM) has been used to produce visceral malformations in fetuses to explain...
The Adriamycin rat model (ARM) has been used to produce visceral malformations in fetuses to explain...
A single dose of cyclophosphamide (20 mg/kg) was administered to female rats on Day 12 of gestation....
Graduation date: 1986Two experiments were conducted to assess the effects\ud of paralysis and oligoh...
Dysraphism is a defect in neural tube development, leading to dysplastic growth of the spinal cord a...
The features of 27 cases of limb/body wall deficiency (formerly termed cyllosomus and pleurosomus) w...
In this paper we report a case of early onset fetal akinesia, with unusual pathological findings. T...
Fetal Akinesia Deformation Sequence (FADS) is a condition characterised by decreased fetal movement ...
Fetal akinesia deformation sequence (FADS), or Pena-Shokeir phenotype is a constellation of deformat...
Experimental oligohydramnios has been induced in pregnant rats on the 15th gestational day. Characte...
AbstractFetal akinesia deformation sequence is a clinically and genetically heterogeneous disorder c...
Fakinesia deformation sequence (FADS) represents a group of disorders resulting from absent or dimin...
[[abstract]]Fetal akinesia deformation sequence is a clinically and genetically heterogeneous disord...
The aim of this study was to validate a model of skeletal anomalies in rat fetuses by the administra...
Fetal akinesia refers to a broad spectrum of disorders in which the unifying feature is a reduction ...
The Adriamycin rat model (ARM) has been used to produce visceral malformations in fetuses to explain...
The Adriamycin rat model (ARM) has been used to produce visceral malformations in fetuses to explain...
A single dose of cyclophosphamide (20 mg/kg) was administered to female rats on Day 12 of gestation....
Graduation date: 1986Two experiments were conducted to assess the effects\ud of paralysis and oligoh...
Dysraphism is a defect in neural tube development, leading to dysplastic growth of the spinal cord a...
The features of 27 cases of limb/body wall deficiency (formerly termed cyllosomus and pleurosomus) w...
In this paper we report a case of early onset fetal akinesia, with unusual pathological findings. T...
Fetal Akinesia Deformation Sequence (FADS) is a condition characterised by decreased fetal movement ...
Fetal akinesia deformation sequence (FADS), or Pena-Shokeir phenotype is a constellation of deformat...
Experimental oligohydramnios has been induced in pregnant rats on the 15th gestational day. Characte...
AbstractFetal akinesia deformation sequence is a clinically and genetically heterogeneous disorder c...
Fakinesia deformation sequence (FADS) represents a group of disorders resulting from absent or dimin...
[[abstract]]Fetal akinesia deformation sequence is a clinically and genetically heterogeneous disord...
The aim of this study was to validate a model of skeletal anomalies in rat fetuses by the administra...
Fetal akinesia refers to a broad spectrum of disorders in which the unifying feature is a reduction ...
The Adriamycin rat model (ARM) has been used to produce visceral malformations in fetuses to explain...
The Adriamycin rat model (ARM) has been used to produce visceral malformations in fetuses to explain...
A single dose of cyclophosphamide (20 mg/kg) was administered to female rats on Day 12 of gestation....